Oramed Pharmaceuticals (ORMP) had the highest return since January 31, 2004 and in April 2004 by a US stock in the Nasdaq Composite (IXIC), returning 8,155%.
| ASSET | % RETURN |
|---|---|
Oramed Pharmaceuticals (ORMP) | 8,155% |
Cytokinetics (CYTK) | 550.39% |
Red Cat (RCAT) | 328.57% |
Worksport (WKSP) | 292.16% |
Hallador Energy (HNRG) | 196.3% |
Franklin Wireless (FKWL) | 133.33% |
Anixa Biosciences (ANIX) | 129.79% |
LifeMD (LFMD) | 86.67% |
Sanara Medtech (SMTI) | 84.62% |
ANI Pharmaceuticals (ANIP) | 59.76% |
Champions Oncology (CSBR) | 50% |
VirTra (VTSI) | 47.06% |
Marchex (MCHX) | 41.05% |
Natural Health Trend (NHTC) | 40.94% |
Key Tronic (KTCC) | 37.84% |
PowerFleet (AIOT) | 34.09% |
Terawulf (WULF) | 32.58% |
Consumer Portfolio Services (CPSS) | 32.28% |
CSP (CSPI) | 32% |
Value Line (VALU) | 31.64% |
EDAP TMS (FOCL) | 30.73% |
Alterity Therapeutics (ATHE) | 30.21% |
Ascent Industries (ACNT) | 28.42% |
Gaia (GAIA) | 28.02% |
Lakeland Industries (LAKE) | 27.93% |